Overbought Stochastic RSI flags correction risk as INJ stalls below resistance: weekly outlook

Traders Union
All News
Crypto
Injective rises 15.70% this week

Highlights

Injective trades at $8.14 after a 15.7% move higher in the past 7 days, maintaining a bullish long-term structure.
Short-term technicals indicate consolidation above the $8.12 support with overbought conditions introducing possible correction risk.
The 7-day expected range is $7.3 to $8.99, with a base case of consolidation between $8.12 and $8.58.

ETF debut and token anniversary drive robust flows and record onchain volumes

Canary Capital launched the first U.S. spot staked ETF for INJ on Nasdaq in early November, providing investors direct exposure and staking rewards, according to GlobeNewswire. The ETF, which aims to stake up to 90% of its holdings and uses BitGo for custody, allows easy access for traditional brokerage account holders, as reported by TokenPost. By Friday, November 8, crypto.news noted the fund had accumulated $16.12 million in assets. This period also marked the fifth anniversary of INJ, with onchain trading volume exceeding $12.86 billion according to TokenPost.

Mixed momentum signals emerge as rally stalls near key resistance

On the daily chart, Injective is consolidating after a sharp move higher without a sustained trend, as volatility reached 22.57%. Momentum readings are mixed: Stochastic RSI is currently overbought (87.38), suggesting short-term overheating and possible correction risk, while MACD and Bull/Bear Power remain positive. The price is holding at support from the Ichimoku Kijun at $8.12, with resistance overhead at $8.58. This setup points to consolidation with a slight upward bias, but overbought conditions introduce near-term risks.

Upside breakout risk grows as price consolidates above support

Over the next 7 days, the expected range is $7.3 to $8.99, with a very high probability of an increase and a very low probability of a decrease. The base case is consolidation between $8.12 support and $8.58 resistance. A sustained break above $8.58 could open the way toward $8.99, while a move below $8.12 would shift focus to the lower end of the range near $7.3.

Jainam Mehta, market strategist, notes that Injective (INJ) has rallied 16% over the past week to $8.14 as institutional flows picked up following the launch of the first U.S. spot staked ETF for INJ on Nasdaq. He views this milestone as a catalyst for renewed attention among traditional investors, especially given the $16.12 million in assets accumulated by the fund in its first days. On the daily chart, price is consolidating atop $8.12 support with mixed momentum — while overbought readings flag the risk of a short-term pullback, structural appetite from new ETF flows may support price as long as key supports hold. "The base case is sideways to slightly higher within the $8.12–$8.58 range this week, but fatigue in momentum suggests not chasing high prints — instead, I’ll watch for either consolidation to reset conditions or a potential breakout above $8.58 as a tactical signal."

Earlier, analysts noted that Injective led crypto gains following the launch approval of a staked INJ ETF on Nasdaq, amid signs of shifting risk appetite across digital assets. Building on this, the current article shows that while ETF inflows have continued to support INJ's price action, traders should watch for further volatility, with the $8.58 resistance level representing a key pivot for the token's next move.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.